The Epstein-Barr virus (EBV) DNA polymerase accessory protein, BMRF1, activates the essential downstream component of the EBV oriLyt

Virology

Volumn 230, Issue 1, 1997, Pages 22-34

  Zhang, Qin ^b   Holley Guthrie, Elizabeth ^b   Ge, Ji Qian ^b   Dorsky, David ^c   Kenney, Shannon ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; DNA POLYMERASE ACCESSORY PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA BINDING; DNA TRANSCRIPTION; EPSTEIN BARR VIRUS; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; VIRUS REPLICATION;

HUMAN HERPESVIRUS 4;

EID: 0031592603     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8470     Document Type: Article

References (66)

1. Baer R., Bankier A., Biggen M., Deininger P., Farrell P., Gibson T., Hatfull G., Hudson G., Satchwell S., Sequin C., Tuffnell P., Barrell B. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature. 310:1984;207-211.
2. Briggs M., Kadonaga J., Bell S., Tjian R. Purification and biochemical characterization of the promoter-specific transcription factor Sp1. Science. 232:1986;485-487.
3. Buisson M., Manet E., Trescol-Biemont M. C., Gruffat H., Durand B., Sergeant A. The Epstein-Barr virus early protein EB2 is a post-transcriptional activator expressed under control of EBV transcription factors EB1 and R. J. Virol. 635:1989;276-5284.
4. Chen L-W., Lin L-S., Chang Y. S., Liu S. T. Functional analysis of EA-D of Epstein-Barr virus. Virology. 211:1995;593-597.
5. Chevallier-Greco A., Gruffat H., Manet E., Calender A., Sergeant A. The Epstein-Barr virus (EBV) DR enhancer contains two functionally different domains: Domain A is constitutive and cell specific, domain B is transactivated by the EBV early protein R. J. Virol. 63:1989;615-623.
6. Chevallier-Greco A., Manet E., Chavrier P., Mosnier C., Daillie J., Sergeant A. Both Epstein-Barr virus (EBV) encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an early EBV promoter. EMBO J. 5:1986;3243-3249.
7. Chiou J. F., Li J. K., Cheng Y. C. Demonstration of a stimulatory protein for virus-specified DNA polymerase in phorbol ester-treated Epstein-Barr virus-carrying cells. Proc. Natl. Acad. Sci. USA. 82:1985;5728-5731.
8. Cho M. S., Milman G., Hayward S. D. A second Epstein-Barr virus early antigen gene in BamHI fragment M encodes a 48- to 50-kilodalton nuclear protein. J. Virol. 56:1985;860-866.
9. Countryman J., Miller G. Activation of expression of latent Epstein-Barr virus after gene transfer with a small cloned fragment of heterogeneous viral DNA. Proc. Natl. Acad. Sci. USA. 82:1985;4085-4089.
10. Courey A., Tjian R. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation domain. Cell. 55:1988;887-898.
11. Cox M., Leahy J., Hardwick J. M. An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators. J. Virology. 64:1990;313-321.
12. DiNocera P., Dawid I. Transient expression of genes introduced into cultured cells of Drosophila. Proc. Natl. Acad. Sci. USA. 80:1983;7095-7098.
13. Dynan W., Tjian R. The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell. 35:1983;79-87.
14. Farrell P., Rowe D., Rooney C., Kouzarides T. Epstein-Barr virus BZLF1 trans-activator specifically binds to consensus Ap1 site and is related to c-fos. EMBO J. 8:1989;127-132.
15. Fixman E., Hayward G., Hayward S. D. Trans-acting requirements for replication of Epstein-Barr virus oriLyt. J. Virol. 66:1992;5030-5039.
16. Fixman E., Hayward G., Hayward S. D. Replication of Epstein-Barr virus oriLyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays. J. Virol. 69:1995;2998-3006.
17. Garner M., Revzin A. A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: Application to components of the Escherichia coli lactose operon regulatory system. Nucleic Acids Res. 9:1981;3047-3060.
18. Glaser R., O'Neill F. J. Hybridization of Burkitt Lymphoblastoid Cells. Science. 176:1972;1245-1247.
19. Gorman C., Moffat L., Howard B. Recombinant genomes which express chloramphenicol acetyl transferase in mammalian Cells. Mol. Cell. Biol. 2:1982;1044-1051.
20. Gruffat H., Renner O., Pich D., Hammerschmidt W. Cellular proteins bind to the downstream component of the lytic origin of DNA replication of Epstein-Barr virus. J. Virol. 69:1995;1878-1886.
21. Guo Z., DePamphilis M. Specific transcription factors stimulate transcription of simian virus 40 and polyomavirus origins of DNA replication. Mol. Cell. Biol. 12:1992;2514-2524.
22. Hammerschmidt W., Sugden B. Identification and characterization of oriLyt, a lytic origin of replication of Epstein-Barr virus. Cell. 5:1988;427-433.
23. Hardwick J. M., Lieberman P., Hayward S. D. A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen. J. Virol. 62:1988;2274-2284.
24. Hardwick J. M., Tse L., Applegren N., Nicholas J., Veliuona M. A. The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16. J. Virol. 66:1992;5500-5508.
25. Hatfield L., Hearing P. The NFIII/Oct-1 binding site stimulates adenovirus DNA replication in vivo and is functionally redundant with adjacent sequences. J. Virol. 67:1993;3931-3939.
26. Henderson S., Huen D., Rowe M., Dawson C., Johnson G., Rickinson A. B. Epstein-Barr virus-encoded BHRF1 protein, a viral homolog of Bcl2, protects human B Cells from programmed Cell death. Proc. Natl. Acad. Sci. USA. 90:1993;8479-8483.
27. Holley-Guthrie E., Quinlivan E., Mar E., Kenney S. The Epstein-Barr virus promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell specific manner. J. Virol. 64:1990;3753-3759.
28. Kadonaga J., Carner K., Masiarz F., Tjian R. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell. 51:1987;1079-1090.
29. Kallin B., Sternas L., Saemundssen A., Luka J., Jornvall H., Eriksson B., Tao P., Nilsson T., Klein G. Purification of the Epstein-Barr virus DNA polymerase from P3HR-1 Cells. J. Virol. 54:1985;561-568.
30. Kamine J., Subramanian T., Chinnadurai G. Sp1-dependent activation of a synthetic promoter by human immunodeficiency type I TAT protein. Proc. Natl. Acad. Sci. USA. 88:1991;8510-8514.
31. S. Kennett, A. Udvadia, J. Horowitz, 1997, Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription.
32. Kenney S., Kamine J., Holley-Guthrie E., Lin J., Mar E., Pagano J. The EBV BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters. J. Virol. 63:1989;1729-1736.
33. Kieff E., Leibowitz D. Epstein-Barr virus and its replication. Fields Virology. 1990;Raven Press, New York. p. 1889-1920.
34. Kiehl A., Dorsky D. I. Cooperation of EBV DNA polymerase and EA-D (BMRF1)in vitro. Virology. 184:1991;330-340.
35. Kiehl A., Dorsky D. Bipartite DNA-binding region of the Epstein-Barr virus BMRF1 product essential for DNA polymerase accessory function. J. Virol. 69:1995;1669-1677.
36. Kim S., Onwuta U., Lee Y., Li R., Botchan M., Robbins P. The retinoblastoma gene product regulates Sp1-mediated transcription. Mol. Cell. Biol. 12:1992;2455-2463.
37. Laimins L., Gruss P., Pozatti R., Khoury G. Characterization of enhancer elements in the long terminal repeat of Moloney murine sarcoma virus. J. Virol. 49:1984;183-189.
38. Laux G., Freese U. K., Bornkamm G. W. Structure and evolution two related transcription units of Epstein-Barr virus carrying small tandem repeats. J. Virol. 56:1985;987-995.
39. Li Q., Young L., Niedobitek G., Dawson C., Birkenbach M., Wang F., Rickenson A. Epstein-Barr virus infection and replication in a human epithelial system. Nature. 356:1992;347-350.
40. Li R., Knight J., Jackson S., Tjian R., Botchan M. Direct interaction between the Sp1 and BPV enhancer E2 protein mediates synergistic activation of transcription. Cell. 65:1991;493-505.
41. Li J. S., Zhou B. S., Dutschman G. E., Grill S. P., Tan R. S., Cheng Y. C. Association of Epstein-Barr virus early antigen diffuse component and virus-specified DNA polymerase activity. J. Virol. 61:1987;2947-2949.
42. Lieberman P., Harwick J. M., Hayward S. D. Responsiveness of the Epstein-Barr virus NotI Repeat promoter to the Z transactivator is mediated in a cell-type specific manner by two independent signal regions. J. Virol. 63:1989;3040-3050.
43. Lillie J., Green M. Transcriptional activation by the adenovirus E1a protein. Nature. 338:1979;39-49.
44. Luka J., Kallin B., Klein G. Induction of the Epstein-Barr virus cycle in latently infected Cells by n-butyrate. Virology. 94:1979;228-231.
45. Miller G. The Epstein-Barr virus. Fields B., Knipe D. Fields Virology. 1990;1921-1957 Raven Press, New York.
46. Oguro M., Shimizu N., Ono Y., Takada K. Both the rightward and the leftward open reading frames within the BamHI M DNA fragment of Epstein-Barr virus act as trans-activators of gene expression. J. Virol. 61:1987;3310-3313.
47. Pearson G. R., Vroman B., Chase B., Sculley T., Hummel M., Kieff E. Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies. J. Virol. 47:1983;193-201.
48. Quinlivan E., Holley-Guthrie E., Norris M., Gutsch D., Bachenheimer S., Kenney S. Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1. Nucleic Acids Res. 21:1993;1999-2007.
49. Reissman D., Yates J., Sugden B. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol. Cell. Biol. 5:1985;1822-1932.
50. Rooney C., Taylor N., Countryman J., Jenson H., Kolman J., Miller G. Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency. Proc. Natl. Acad. Sci. USA. 85:1988;9801-9805.
51. Schepers A., Pich D., Hammerschmidt W. A transcription factor with homology to the Ap1 family links RNA transcription and DNA replication in the lytic cycle of Epstein-Barr virus. EMBO J. 12:1993;3921-3929.
52. Schepers A., Pich D., Mankertz J., Hammerschmidt W. Cis-acting elements in the lytic origin of DNA replication of Epstein-Barr virus. J. Virol. 67:1993;4237-4245.
53. Schneider I. Cell lines derived from late embryonic stages of Drosophila melanogaster. J. Embryol. Exp. Morphol. 27:1972;353-365.
54. Sixby J., Nedrud J., Raab-Traub N., Hanes R., Pagano J. Epstein-Barr replication in oropharynx epithelial cells. N. Engl. J. Med. 310:1984;1225-1230.
55. Takada K., Shimuzu N., Sakuma S., Keating A. Transactivation of the latent Epstein-Barr virus genome after transfection of the EBV Bam H1 Z DNA fragment. J. Virol. 57:1986;1011-1022.
56. Takada K., Ono Y. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 63:1989;445-449.
57. Takagi S., Takada K., Sairenji T. Formation of intranuclear replication compartments of Epstein-Barr virus with redistribution of BZLF1 and BMRF1 gene products. Virology. 185:1991;309-315.
58. Tsurumi T. Purification and characterization of the DNA-binding activity of the Epstein-Barr virus DNA polymerase accessory protein BMRF1 gene products, as expressed in insect cells by using the baculovirus system. J. Virol. 67:1993;1681-1687.
59. Tsurumi T., Daikoku T., Kurachi R., Nishiyama Y. Functional interaction between Epstein-Barr virus DNA polymerase catalytic subunit and its accessory subunitin vitro. J. Virol. 67:1993;7648-7653.
60. Wang X., Ooi B. G., Miller L. K. Baculovirus vectors for multiple gene expression and for occluded virus production. Gene. 100:1991;131-137.
61. Wong K., Levine A. Identification and mapping of the Epstein-Barr virus early antigens and demonstration of a viral activator that functions in trans. J. Virol. 65:1986;2601-2611.
62. Yates J., Warren N., Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature. 313:1985;812-815.
63. Zalani S., Holley-Guthrie E., Kenney S. Epstein-Barr viral latency is disrupted by the Immediate-early BRLF1 protein through a cell-specific mechanism. Proc. Natl. Acad. Sci. USA. 93:1996;9194-9199.
64. Zalani S., Holley-Guthrie E., Gutsch D., Kenney S. The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factor. J. Virol. 66:1992;7282-7292.
65. Zhang Q., Hong Y., Dorsky D., Holley-Guthrie E., Zalani S., Aly Elshiekh N., Kiehl A., Le T., Kenney S. Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication. J. Virol. 70:1996;5131-5142.
66. Zur Hausen H., Bornkamm G., Schmidt R., Hecker E. Tumor initiators and promoters in the induction of Epstein-Barr virus. Proc. Natl. Acad. Sci. USA. 76:1979;782-785.